Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.30M | 85.10M | 86.70M | 87.60M | 79.13M | 65.48M |
Gross Profit | 15.80M | 37.70M | 81.60M | 79.10M | 37.63M | 30.25M |
EBITDA | 29.10M | -12.50M | 58.30M | 57.70M | 40.50M | 26.58M |
Net Income | -10.10M | -20.10M | 11.40M | 10.90M | 3.80M | -2.21M |
Balance Sheet | ||||||
Total Assets | 693.20M | 601.60M | 1.26B | 1.38B | 1.15B | 908.20M |
Cash, Cash Equivalents and Short-Term Investments | 71.60M | 55.70M | 46.70M | 118.20M | 57.29M | 91.60M |
Total Debt | 601.70M | 516.90M | 1.16B | 1.22B | 1.05B | 851.90M |
Total Liabilities | 636.80M | 542.30M | 1.19B | 1.27B | 1.10B | 898.20M |
Stockholders Equity | 56.40M | 59.30M | 76.50M | 103.30M | 48.25M | 10.00M |
Cash Flow | ||||||
Free Cash Flow | -160.70M | 25.40M | -25.40M | 36.30M | -218.53M | -404.66M |
Operating Cash Flow | -159.60M | 28.60M | -18.90M | 39.70M | -216.12M | -401.11M |
Investing Cash Flow | -11.20M | -16.90M | 11.70M | -191.00M | -2.43M | -3.47M |
Financing Cash Flow | 154.40M | -2.70M | -64.30M | 207.30M | 189.10M | 456.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £1.79B | 9.16 | 14.68% | 5.92% | 27.88% | 28.92% | |
77 Outperform | £1.88B | 6.63 | 13.70% | 6.63% | 18.67% | 17.42% | |
68 Neutral | £865.55M | 20.57 | 3.67% | ― | -11.82% | -54.07% | |
63 Neutral | $543.67M | 4.53 | -6.71% | ― | 3.73% | -172.06% | |
58 Neutral | $12.60B | 5.37 | -2.71% | 5.54% | 5.88% | -56.09% | |
54 Neutral | £54.72M | ― | -16.30% | ― | -10.35% | 18.10% |